Keurig Dr Pepper (NASDAQ:KDP – Get Free Report) had its price objective cut by equities researchers at Citigroup from $43.00 to $40.00 in a report released on Friday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. Citigroup’s price target suggests a potential upside of 15.67% from the stock’s previous close.
Several other brokerages also recently issued reports on KDP. TD Cowen raised their price target on Keurig Dr Pepper from $35.00 to $40.00 and gave the company a “hold” rating in a research report on Thursday, September 26th. Jefferies Financial Group dropped their price target on Keurig Dr Pepper from $42.00 to $41.00 and set a “buy” rating on the stock in a research report on Friday. Barclays upped their price target on Keurig Dr Pepper from $37.00 to $41.00 and gave the stock an “overweight” rating in a report on Friday, October 11th. Wells Fargo & Company lowered their price objective on shares of Keurig Dr Pepper from $43.00 to $42.00 and set an “overweight” rating on the stock in a research note on Friday. Finally, Evercore ISI upgraded shares of Keurig Dr Pepper to a “hold” rating in a research note on Thursday, September 5th. Seven research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $38.50.
Read Our Latest Report on Keurig Dr Pepper
Keurig Dr Pepper Stock Down 1.0 %
Keurig Dr Pepper (NASDAQ:KDP – Get Free Report) last issued its quarterly earnings data on Thursday, October 24th. The company reported $0.51 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.51. Keurig Dr Pepper had a net margin of 14.47% and a return on equity of 10.32%. The business had revenue of $3.89 billion during the quarter, compared to analysts’ expectations of $3.92 billion. During the same period in the previous year, the company earned $0.48 earnings per share. Keurig Dr Pepper’s revenue for the quarter was up 2.3% on a year-over-year basis. As a group, research analysts predict that Keurig Dr Pepper will post 1.92 EPS for the current year.
Hedge Funds Weigh In On Keurig Dr Pepper
Several hedge funds and other institutional investors have recently modified their holdings of the stock. Blue Trust Inc. raised its stake in Keurig Dr Pepper by 312.1% during the second quarter. Blue Trust Inc. now owns 849 shares of the company’s stock worth $26,000 after acquiring an additional 643 shares in the last quarter. Whittier Trust Co. of Nevada Inc. boosted its stake in shares of Keurig Dr Pepper by 617.1% in the 2nd quarter. Whittier Trust Co. of Nevada Inc. now owns 796 shares of the company’s stock valued at $27,000 after purchasing an additional 685 shares in the last quarter. Farmers & Merchants Investments Inc. grew its holdings in shares of Keurig Dr Pepper by 51.5% in the 2nd quarter. Farmers & Merchants Investments Inc. now owns 886 shares of the company’s stock worth $30,000 after purchasing an additional 301 shares during the last quarter. Hantz Financial Services Inc. acquired a new stake in shares of Keurig Dr Pepper during the 2nd quarter worth about $35,000. Finally, Riverview Trust Co bought a new position in Keurig Dr Pepper during the 2nd quarter valued at about $39,000. Institutional investors own 85.23% of the company’s stock.
Keurig Dr Pepper Company Profile
Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.
Further Reading
- Five stocks we like better than Keurig Dr Pepper
- Trading Stocks: RSI and Why it’s Useful
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- The Significance of Brokerage Rankings in Stock Selection
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
- How to Plot Fibonacci Price Inflection Levels
- MarketBeat Week in Review – 10/21- 10/25
Receive News & Ratings for Keurig Dr Pepper Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Keurig Dr Pepper and related companies with MarketBeat.com's FREE daily email newsletter.